Correction for Kovacs et al., “An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline”

類似資料

• An Open-Label Study of the Impact of Hepatic Impairment on the Pharmacokinetics and Safety of Single Oral and Intravenous Doses of Omadacycline
  著者:: Kovacs, Steven J., 等
  出版事項: (2020)
• Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects
  著者:: Sun, Haiying, 等
  出版事項: (2016)
• Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of (14)C-Omadacycline in Rats
  著者:: Lin, Wen, 等
  出版事項: (2016)
• Pharmacokinetics and Pharmacodynamics of Oral and Intravenous Omadacycline
  著者:: Rodvold, Keith A, 等
  出版事項: (2019)
• In Vitro and In Vivo Assessments of Cardiovascular Effects with Omadacycline
  著者:: Tanaka, S. Ken, 等
  出版事項: (2016)